InspireMD, Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| NSPR | RMD | |
|---|---|---|
| Market Cap | $36.53 million | $32.46 billion |
| Revenue (TTM) | $10.84 million | $5.65 billion |
| Net Income (TTM) | $-52,482,000 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| NSPR | RMD | |
|---|---|---|
| P/E Ratio | — | 21.57 |
| Price / Book | 1.16 | 4.93 |
| Price / Sales | 3.37 | 5.74 |
NSPR leads on 2 of 2 valuation factors.
Profitability
| NSPR | RMD | |
|---|---|---|
| Net Margin | -484.11% | 26.94% |
| Return on Equity | -166.55% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| NSPR | RMD | |
|---|---|---|
| Dividend Yield | — | 1.17% |
| Payout Ratio | — | 25.31 |
NSPR and RMD split the dividend factors evenly.
Risk & Sentiment
| NSPR | RMD | |
|---|---|---|
| Short Interest | 3.14% | 4.04% |
NSPR leads on 1 of 1 risk & sentiment factors.
Dig deeper: NSPR overview, NSPR financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.